Citation | Martin, MW; Newcomb, J; Nunes, JJ; Boucher, C; Chai, L; Epstein, LF; Faust, T; Flores, S; Gallant, P; Gore, A; Gu, Y; Hsieh, F; Huang, X; Kim, JL; Middleton, S; Morgenstern, K; Oliveira-dos-Santos, A; Patel, VF; Powers, D; Rose, P; Tudor, Y; Turci, SM; Welcher, AA; Zack, D; Zhao, H; Zhu, L; Zhu, X; Ghiron, C; Ermann, M; Johnston, D; Saluste, CG Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity. J Med Chem51:1637-48 (2008) [PubMed] Article |
---|
SMILES | COc1ccc(Cl)cc1-n1c2nc3ccccc3n2c2nc(Nc3ccc(cc3)N3CCN(C)CC3)ncc2c1=O |(29.7,-42.87,;29.7,-44.41,;31.04,-45.18,;32.37,-44.41,;33.71,-45.18,;33.7,-46.72,;35.03,-47.5,;32.37,-47.49,;31.04,-46.72,;29.71,-47.48,;29.7,-49.03,;30.85,-50.07,;30.21,-51.47,;30.83,-52.87,;29.93,-54.11,;28.39,-53.94,;27.78,-52.53,;28.69,-51.3,;28.37,-49.8,;27.03,-49.03,;25.69,-49.8,;24.36,-49.03,;23.03,-49.8,;21.7,-49.03,;21.71,-47.49,;20.38,-46.72,;19.04,-47.48,;19.04,-49.03,;20.38,-49.8,;17.71,-46.71,;17.71,-45.18,;16.39,-44.41,;15.05,-45.17,;13.72,-44.4,;15.04,-46.71,;16.38,-47.49,;24.37,-47.49,;25.69,-46.72,;27.03,-47.48,;28.37,-46.7,;28.36,-45.16,)| |